Cartesian Therapeutics (RNAC) Interest Coverage Ratio (2016 - 2023)
Historic Interest Coverage Ratio for Cartesian Therapeutics (RNAC) over the last 9 years, with Q3 2023 value amounting to 10.26.
- Cartesian Therapeutics' Interest Coverage Ratio fell 41476.25% to 10.26 in Q3 2023 from the same period last year, while for Jun 2024 it was 38.48, marking a year-over-year decrease of 15884.13%. This contributed to the annual value of 30.5 for FY2023, which is 73595.86% down from last year.
- According to the latest figures from Q3 2023, Cartesian Therapeutics' Interest Coverage Ratio is 10.26, which was down 41476.25% from 24.78 recorded in Q2 2023.
- In the past 5 years, Cartesian Therapeutics' Interest Coverage Ratio registered a high of 19.38 during Q2 2022, and its lowest value of 79.84 during Q2 2020.
- Its 5-year average for Interest Coverage Ratio is 19.9, with a median of 11.08 in 2020.
- As far as peak fluctuations go, Cartesian Therapeutics' Interest Coverage Ratio soared by 294921.72% in 2022, and later crashed by 41476.25% in 2023.
- Over the past 5 years, Cartesian Therapeutics' Interest Coverage Ratio (Quarter) stood at 37.52 in 2019, then skyrocketed by 70.48% to 11.08 in 2020, then surged by 151.78% to 5.74 in 2021, then tumbled by 283.55% to 10.53 in 2022, then rose by 2.51% to 10.26 in 2023.
- Its Interest Coverage Ratio was 10.26 in Q3 2023, compared to 24.78 in Q2 2023 and 22.75 in Q1 2023.